These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9333593)

  • 21. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrolytes in cardiac arrhythmias. Especially effective in coronary heart disease patients].
    Manz M; Susilo R
    MMW Fortschr Med; 2002 Mar; 144(10):48. PubMed ID: 11928266
    [No Abstract]   [Full Text] [Related]  

  • 24. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium therapy in ventricular arrhythmias.
    Keren A; Tzivoni D
    Pacing Clin Electrophysiol; 1990 Jul; 13(7):937-45. PubMed ID: 1695751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proarrhythmic actions of antiarrhythmic drugs: a review.
    Campbell TJ
    Aust N Z J Med; 1990 Jun; 20(3):275-82. PubMed ID: 2196873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Marked reduction of life-threatening ventricular tachyarrhythmias in a critically ill patient by intravenous administration of magnesium sulfate].
    Chang KH; Uchikoba K; Obara M; Chinzei M; Sumida T; Arita E; Hanaoka K
    Masui; 2002 Jan; 51(1):56-60. PubMed ID: 11840666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effects of magnesium sulphate. Report of three cases.
    Knudsen K; Abrahamsson J
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):850-4. PubMed ID: 7484048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
    Yusu S; Ikeda T; Mera H; Miyakoshi M; Miwa Y; Abe A; Tsukada T; Ishiguro H; Shimizu H; Yoshino H
    Circ J; 2009 Nov; 73(11):2021-8. PubMed ID: 19724153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium and the heart: antiarrhythmic therapy with magnesium.
    Fazekas T; Scherlag BJ; Vos M; Wellens HJ; Lazzara R
    Clin Cardiol; 1993 Nov; 16(11):768-74. PubMed ID: 8269653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of magnesium in cardiac tachyarrhythmias.
    Iseri LT
    Am J Cardiol; 1990 Jun; 65(23):47K-50K. PubMed ID: 2353670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias.
    Perticone F; Ceravolo R; De Novara G; Torchia L; Cloro C
    Magnes Res; 1992 Dec; 5(4):265-72. PubMed ID: 1296762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction.
    Kato M; Dote K; Sasaki S; Takemoto H; Habara S; Hasegawa D
    Chest; 2004 Sep; 126(3):702-8. PubMed ID: 15364745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of low potassium or magnesium concentrations on isolated cardiac tissue.
    Roden DM; Iansmith DH
    Am J Med; 1987 Mar; 82(3A):18-23. PubMed ID: 3565423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmias.
    Echt DS; Lee JT; Murray KT; Vorperian V; Borganelli SM; Crawford DM; Friedrich T; Roden DM
    J Cardiovasc Electrophysiol; 1995 Sep; 6(9):687-99. PubMed ID: 8556189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.